Literature DB >> 30666404

HMG-CoA reductase expression in human eyelid tissue and in a human meibomian gland epithelial cell line.

Kenneth G-J Ooi1,2,3, Anupam Rao4, Jonathan S-K Goh4, Gary Gracie5, Svetlana Cherepanoff6,7,5, Michele C Madigan4,8, Stephanie L Watson4,6,7.   

Abstract

PURPOSE: 3-Hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), the rate-limiting enzyme of cholesterol production, has been found to contribute to lipid secretion from skin sebaceous glands and hair follicles. We assessed for HMGCR expression in human eyelid tissue and in immortalized human meibomian gland epithelial cells (HMGECs) using immunohistochemistry.
METHODS: Full thickness human eyelid specimens in archival paraffin blocks were obtained. A section from each block was stained with hematoxylin and eosin and examined by an ocular pathologist for validation of tissue pathology. Immunohistochemistry was performed using rabbit anti-human HMGCR antibody on serial sections using the Ventana automated staining system. HMGCR expression was examined for in HMEGCs with fluorescence immunocytochemistry and confocal microscopy.
RESULTS: Thirteen full thickness eyelid specimens met the inclusion criteria. All specimens contained meibomian glands, and 2 (15%) contained glands of Zeis, 3 (23%) pilosebaceous glands, 2 (15%), accessory lacrimal glands, and 2 (15%), glands of Moll, respectively. Immunohistochemistry showed HMGCR expression in meibocytes of meibomian glands and sebocytes of Zeis and pilosebaceous glands in all specimens. HMGCR expression was also evident in vascular endothelium. Immunofluorescence was positive for HMGCR expression on HMGEC cells. No labeling was seen for the negative Ig control.
CONCLUSION: HMGCR was expressed in all eyelid sebaceous-type glands and in HMGECs, consistent with a role for cholesterol production in the genesis of tear film lipids. The observed expression also provides a rationale for using topical statins, inhibitors of HMGCR, as novel tear film lipid stabilizers in conditions such as blepharitis, where meibum production is aberrant.

Entities:  

Keywords:  Blepharitis; Cholesterol; Dry eye; HMG-CoA reductase; Meibomian gland; Statin; Vascular endothelium

Mesh:

Substances:

Year:  2019        PMID: 30666404     DOI: 10.1007/s00417-019-04247-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Association of Dry Eye Disease With Dyslipidemia and Statin Use.

Authors:  Khalid M Aldaas; Omar M Ismail; Judi Hakim; Eric D Van Buren; Feng-Chang Lin; Joshua S Hardin; Jay J Meyer
Journal:  Am J Ophthalmol       Date:  2020-05-12       Impact factor: 5.258

2.  Statin Use Is Associated With a Lower Risk of Blepharitis: A Population-Based Study.

Authors:  Kathy Ming Feng; Chi-Hsiang Chung; Yi-Hao Chen; Wu-Chien Chien; Ke-Hung Chien
Journal:  Front Med (Lausanne)       Date:  2022-03-15

3.  Dynamic Changes in the Gene Expression Patterns and Lipid Profiles in the Developing and Maturing Meibomian Glands.

Authors:  Igor A Butovich; Amber Wilkerson
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

4.  Association of Meibomian Gland Dysfunction with Oral Statin Use.

Authors:  Sun-Kyoung Park; Ji-Hye Lee; Ho-Sik Hwang; Hyun-Seung Kim; Kyung-Do Han; Kyung-Sun Na
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.